Global Myocardial Infarction Treatment Market Analysis & Trends - Industry Forecast to 2025

  • ID: 3734892
  • Report
  • Region: Global
  • 129 pages
  • Accuray Research LLP
1 of 4
The Global Myocardial Infarction Treatment Market Poised to Grow at a CAGR of Around 3.1% Over the Forecast Period 2015 to 2025

FEATURED COMPANIES

  • Anthera Pharmaceuticals
  • Bayer AG
  • Capricor Inc.
  • Johnson & Johnson
  • Mylan N.V.
  • Pfizer Inc.
  • MORE
This industry report analyzes the global markets for Myocardial Infarction Treatment across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Myocardial Infarction Treatment Market report provides data tables, includes charts and graphs for visual analysis.

The Global Myocardial Infarction Treatment Market is poised to grow at a CAGR of around 3.1% over the forecast period 2015 to 2025.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Anthera Pharmaceuticals
  • Bayer AG
  • Capricor Inc.
  • Johnson & Johnson
  • Mylan N.V.
  • Pfizer Inc.
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Increasing incidence of blood pressures and obesity
3.1.2 Recent Technological Developments of Myocardial Infarction Treatment
3.1.3 Increasing incidence rate of cardiovascular diseases
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Myocardial Infarction Treatment Market, By Product Type
4.1 Antithrombotic agents
4.1.1 Antithrombotic agents Market Forecast to 2025 (US$ MN)
4.1.1.1 Heparin
4.1.1.1.1 Heparin Market Forecast to 2025 (US$ MN)
4.1.1.2 Enoxaparin
4.1.1.2.1 Enoxaparin Market Forecast to 2025 (US$ MN)
4.1.1.3 Bivalirudin
4.1.1.3.1 Bivalirudin Market Forecast to 2025 (US$ MN)
4.2 Analgesics
4.2.1 Analgesics Market Forecast to 2025 (US$ MN)
4.2.1.1 Morphine sulfate
4.2.1.1.1 Morphine sulfate Market Forecast to 2025 (US$ MN)
4.3 Antiplatelet agents
4.3.1 Antiplatelet agents Market Forecast to 2025 (US$ MN)
4.3.1.1 Clopidogrel
4.3.1.1.1 Clopidogrel Market Forecast to 2025 (US$ MN)
4.3.1.2 Vorapaxar
4.3.1.2.1 Vorapaxar Market Forecast to 2025 (US$ MN)
4.3.1.3 Aspirin
4.3.1.3.1 Aspirin Market Forecast to 2025 (US$ MN)
4.4 Angiotensin-Converting Enzyme (ACE) inhibitors
4.4.1 Angiotensin-Converting Enzyme (ACE) inhibitors Market Forecast to 2025 (US$ MN)
4.4.1.1 Lisinopril
4.4.1.1.1 Lisinopril Market Forecast to 2025 (US$ MN)
4.4.1.2 Enalapril
4.4.1.2.1 Enalapril Market Forecast to 2025 (US$ MN)
4.4.1.3 Captopril
4.4.1.3.1 Captopril Market Forecast to 2025 (US$ MN)
4.5 Glycoprotein IIb/IIIa inhibitors
4.5.1 Glycoprotein IIb/IIIa inhibitors Market Forecast to 2025 (US$ MN)
4.5.1.1 Tirofiban
4.5.1.1.1 Tirofiban Market Forecast to 2025 (US$ MN)
4.5.1.2 Abciximab
4.5.1.2.1 Abciximab Market Forecast to 2025 (US$ MN)
4.5.1.3 Eptifibatide
4.5.1.3.1 Eptifibatide Market Forecast to 2025 (US$ MN)
4.6 Thrombolytics
4.6.1 Thrombolytics Market Forecast to 2025 (US$ MN)
4.6.1.1 Alteplase (t-PA)
4.6.1.1.1 Alteplase (t-PA) Market Forecast to 2025 (US$ MN)
4.6.1.2 Tenecteplase
4.6.1.2.1 Tenecteplase Market Forecast to 2025 (US$ MN)
4.7 Beta-adrenergic blockers
4.7.1 Beta-adrenergic blockers Market Forecast to 2025 (US$ MN)
4.7.1.1 Esmolol
4.7.1.1.1 Esmolol Market Forecast to 2025 (US$ MN)
4.7.1.2 Metoprolol
4.7.1.2.1 Metoprolol Market Forecast to 2025 (US$ MN)
4.8 Angiotensin-Receptor blockers
4.8.1 Angiotensin-Receptor blockers Market Forecast to 2025 (US$ MN)
4.8.1.1 Valsartan
4.8.1.1.1 Valsartan Market Forecast to 2025 (US$ MN)
4.8.1.2 Candesartan
4.8.1.2.1 Candesartan Market Forecast to 2025 (US$ MN)

5 Myocardial Infarction Treatment Market, By Distribution channel
5.1 Drug Stores
5.1.1 Drug Stores Market Forecast to 2025 (US$ MN)
5.2 Online drug stores
5.2.1 Online drug stores Market Forecast to 2025 (US$ MN)
5.3 Hospitals
5.3.1 Hospitals Market Forecast to 2025 (US$ MN)
5.4 Hospital Pharmacies
5.4.1 Hospital Pharmacies Market Forecast to 2025 (US$ MN)

6 Myocardial Infarction Treatment Market, By Geography
6.1 North America
6.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
6.2 Europe
6.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
6.3 Asia Pacific
6.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
6.4 Middle East
6.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
6.5 Latin America
6.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
6.6 Rest of the World (RoW)
6.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)

7 Leading Companies
7.1 Portola Pharmaceuticals Inc.
7.2 Mylan N.V.
7.3 Novartis N.V.
7.4 GlaxoSmithKline Plc
7.5 Sandoz Inc.
7.6 Pfizer Inc.
7.7 Sanofi S.A.
7.8 Anthera Pharmaceuticals
7.9 Merck and Co. Inc.
7.10 Boehringer Ingelheim GmbH
7.11 AstraZeneca plc
7.12 Bayer AG
7.13 Bristol-Myers Squibb Company
7.14 Johnson & Johnson
7.15 Capricor Inc.

List of Tables

Table 1 Global Myocardial Infarction Treatment Market By Geography, Market Forecast (2015-2025) (US$ MN)
Table 2 Global Myocardial Infarction Treatment Market By Product Type, Market Forecast (2015-2025) (US$ MN)
Table 3 Global Myocardial Infarction Treatment Market By Distribution channel, Market Forecast (2015-2025) (US$ MN)
Table 4 North America Myocardial Infarction Treatment Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 5 North America Myocardial Infarction Treatment Market By Product Type, Market Forecast (2015-2025) (US$ MN)
Table 6 North America Myocardial Infarction Treatment Market By Distribution channel, Market Forecast (2015-2025) (US$ MN)
Table 7 Europe Myocardial Infarction Treatment Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 8 Europe Myocardial Infarction Treatment Market By Product Type, Market Forecast (2015-2025) (US$ MN)
Table 9 Europe Myocardial Infarction Treatment Market By Distribution channel, Market Forecast (2015-2025) (US$ MN)
Table 10 Asia Pacific Myocardial Infarction Treatment Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 11 Asia Pacific Myocardial Infarction Treatment Market By Product Type, Market Forecast (2015-2025) (US$ MN)
Table 12 Asia Pacific Myocardial Infarction Treatment Market By Distribution channel, Market Forecast (2015-2025) (US$ MN)
Table 13 Middle East Myocardial Infarction Treatment Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 14 Middle East Myocardial Infarction Treatment Market By Product Type, Market Forecast (2015-2025) (US$ MN)
Table 15 Middle East Myocardial Infarction Treatment Market By Distribution channel, Market Forecast (2015-2025) (US$ MN)
Table 16 Latin America Myocardial Infarction Treatment Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 17 Latin America Myocardial Infarction Treatment Market By Product Type, Market Forecast (2015-2025) (US$ MN)
Table 18 Latin America Myocardial Infarction Treatment Market By Distribution channel, Market Forecast (2015-2025) (US$ MN)
Table 19 Rest of the World Myocardial Infarction Treatment Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 20 Rest of the World Myocardial Infarction Treatment Market By Product Type, Market Forecast (2015-2025) (US$ MN)
Table 21 Rest of the World Myocardial Infarction Treatment Market By Distribution channel, Market Forecast (2015-2025) (US$ MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Anthera Pharmaceuticals
- AstraZeneca plc
- Bayer AG
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Capricor Inc.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck and Co. Inc.
- Mylan N.V.
- Novartis N.V.
- Pfizer Inc.
- Portola Pharmaceuticals Inc.
- Sandoz Inc.
- Sanofi S.A.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll